Check-Cap Ltd. announced that on February 18, 2024, Ms. Mira Rosenzweig effectively resigned from her position as chief financial officer ("CFO") of the Company. In connection with Ms. Mira Rosenzweig's resignation, the Company announced that it has appointed Iris Even-Tov as the Interim Chief Financial Officer (the "Interim CFO") of the Company. The Board and the Compensation Committee approved the terms of Iris Even-Tov's compensation as Interim CFO until the next meeting of shareholders of the Company.

Ms. Even-Tov?s has prior experience establishing high-level reporting systems in both the executive and technological levels. Beginning 2019, Ms. Even-Tov most recently served as CFO and controller services for start-up companies and retail companies in the field of medical devices, gaming, software and other like industries. In these roles, Ms. Even-Tov was in charge of managing cash flows, budgetary control, training and supervising bookkeeping, payroll, banks and payments, preparing consolidations in US-GAAP, and overseeing financial reporting to respective management and auditors.

From 2017 to 2019, Ms. Even-Tov served as Director of Finance to BOL Pharma LTD, a start-up company in the field of medical cannabis, and was in charge for, amongst other duties, preparing consolidated financial statements and cash flow, annual business planning, budgetary control, pricing, SaaS metrics and KPI?s, along with working with external auditors, tax preparers and valuation teams. Dan Hilerowitz never held the position of Interim CFO of the Company.